Anal Fistula Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Anal Fistula Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The anal fistula treatment market is expected to register a CAGR of 3.8% over the forecast period.

COVID-19 had a significant impact on the anal fistula treatment market. For instance, as per the article published in 2021 under the title “Insights into the management of anorectal disease in the coronavirus 2019 disease era”, during the COVID-19 pandemic, there was a delay in the treatment of anal fistula, which caused an uncomfortable situation for patients. In such cases, outpatient exploration with proctoscopy, and seton placement, were alternative options based on a previous study in Crohn’s disease patients. Furthermore, as per the blog published in 2021 under the title “Anal Fissure Cases On The Rise In Covid Era; Treatment is Must!”, other than antibiotics, patients overdosing on vitamin, zinc tablets and herbal tonics exacerbated the symptoms of an existing fissure in the long run. Patients with no history of anal fissures also show symptoms of the condition due to these medications during COVID-19. According to the same source, the occurrence of anal fissures had been reported in patients who had previously received COVID-19 treatment. Hence, considering the above-mentioned factors, COVID-19 had a notable impact on the anal fistula treatment market.

The anal fistula treatment market is anticipated to show rapid growth due to the rising cases of inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, the launch of new products, and growing demand for non-surgical methods such as fibrin glue injection, adipose-derived stem cells therapy. For instance, the research, which was carried out by scientists at the University of Nottingham and funded by Crohn’s & Colitis UK and Coeliac UK in 2022 showed that the prevalence of Crohn’s and Colitis in the United Kingdom (UK) population is far higher than previously thought. The same study reported that 1 in every 123 people in the UK have either Crohn’s disease or ulcerative colitis. This amounts to a total of nearly half a million people in the UK living with inflammatory bowel disease (IBD). Therefore, although inflammatory bowel disease is not that common, it still impacts a significant amount of people in the UK.

In addition, there is a rise in demand for safe and effective treatment with no chance of recurrence and fewer side effects which is propelling the key industry players to introduce advanced drugs and devices. Additionally, the technological advancement in anal fistula treatment is boosting market growth. For instance, as per the article published in 2021 under the title “Advances in the Treatment of Anal Fistula: A Mini-Review of Recent Five-Year Clinical Studies”, several combined drainage Seton procedures (pulling Seton, electric-acoustic stimulation (EAS)-sparing Seton after rerouting, and rerouting Seton around the EAS combined with mucosal advancement flap) and LIFT-plug are considered viable therapy for complex anal fistulas. Such advancements in the field of anal fistula treatment are anticipated to boost market growth.

Hence, as per the factors mentioned above, the anal fistula treatment market is likely to witness growth over the forecast period. However, the high cost associated with the anal fistula treatment and lack of awareness regarding the anal fistula treatment restrain the market growth.

Key Market TrendsSurgical Segment is Expected to Dominate the Anal Fistula Treatment Market During the Forecast Period

The surgical treatment for an anal fistula is found to be associated with low recurrence rates, minimal incontinence, and good quality of life. The best option is found to depend on the position of the fistula and whether it is a single channel or branches off in different directions. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. The most common type of surgery for anal fistulas is a fistulotomy.

The surgical segment is found to dominate the anal fistula treatment market due to the increasing incidences of fistula-induced infections, and the rise in demand for safe and effective treatment. For instance, as per the article published in 2021 under the title “Anal Fistula: Contemporary View of Complex Problem”, surgery like fistulotomy has a success rate of more than 90%. As per the same source, medical therapy in combination with surgical solutions is anticipated to significantly reduce the severity of the disease and even hope to eradicate it. Since patients having anal fistula are suggested to go for surgeries to eradicate the problem, the adoption of the surgery segment is likely to increase over the forecast.

Moreover, as per the 2021 update from Cancer.Net, an anal fistula is likely to increase the risk of developing anal/rectal cancer. As per the article published in 2022 under the title “Anal fistula metastasis of rectal cancer after neoadjuvant therapy: a case report”, the study showed the importance of anorectal physical examination before, during, or after neoadjuvant therapy for rectal cancer, because implantation metastasis to the anal fistula is likely to occur any time during treatment. Since the population with the anal fistula along with the risk of rectal cancer is likely to adopt the surgical treatment, the market is expected to grow over the forecast period.

North America is Expected to Dominate the Anal Fistula Treatment Market During the Forecast Period

North America is likely to be dominating the anal fistula market due to a large patient population with inflammatory bowel diseases, early adoption of new technologies, and high healthcare expenditure by the public and private sectors in the studied region. For instance, as per the Mayo Clinic 2022 report, Mayo Clinic surgeons have extensive experience with anal fistulas, treating more than 1,000 people every year in America.

Furthermore, the advancements in the field of the anal fistula market in the studied region are likely to boost the market growth over the forecast period. For instance, in 2021, California-based Ossium Health collaborated with a researcher from Cleveland Clinic for conducting a clinical trial under the title “Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease”, the goal of the study is to investigate the safety and feasibility of using Ossium vertebral Bone Marrow-Derived Mesenchymal Stem Cells (vBM-MSC) to treat people with an ileal pouch-anal anastomosis (IPAA) who develop a fistula in the setting of Crohn's disease of the pouch. Furthermore, in 2020 the same research institution conducted a clinical trial under the title “ Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease (IPAAF)”, the purpose of this study is to evaluate the safety and efficacy of using allogeneic bone marrow-derived mesenchymal stem cells to treat people who have a peri-pouch fistula related to a clinical diagnosis of Crohn's disease of the pouch. Hence, increased research and development in the field of anal fistula are likely to boost market growth over the forecast period.

Furthermore, the presence of competitors, awareness regarding GI diseases, product launches, and acquisitions boosts the market growth in the studied region. For instance, Cross Valley Health & Medicine celebrates National Colorectal Cancer Awareness Month each March. Each year, healthcare providers take this month to provide their patients with extra education about diseases of the colon and rectum. People become more aware of diseases in the rectum as a result of such awareness initiatives by the government and this is likely to promote market growth over the forecast period.

Competitive Landscape

The anal fistula treatment market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The presence of a considerable number of companies is found significantly contributing to market growth. Market players are actively participating in new product launches, collaboration, and development to expand their market share. Key players in the anal fistula treatment market are Cook Group (Cook Medical), KARL STORZ SE & Co. KG, Medtronic plc, Biolitec AG, and others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.